PCS-499

Unknown Manufacturer

PCS-499 is under investigation in clinical trial NCT01487109 (A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients).

Generate AI report

Overview

PCS-499 is under investigation in clinical trial NCT01487109 (A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients).

Technical identifiers

Chemical Formula: C₁₃H₂₀N₄O₃
CAS Number: 1268605-91-9
UNII ID: FLV771E8ZV

Drugs